cell_id,prompt,answer
ACH-000006,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is DOCETAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O. Drug target is Microtubule stabiliser. Drug target pathway is Mitosis.
Drug 3: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Best drug option: ?",AVAGACESTAT
ACH-000021,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is A-770041. The drug SMILES structure is CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=C(C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)C(=NC=N4)N. Drug target is LCK, FYN. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Best drug option: ?",AZD8931
ACH-000045,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 2: The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Best drug option: ?",GSK650394
ACH-000067,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is CRIZOTINIB. The drug SMILES structure is C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N. Drug target is MET, ALK, ROS1. Drug target pathway is RTK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Best drug option: ?",IMATINIB
ACH-000078,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Best drug option: ?",KIN001-135
ACH-000105,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
Drug 2: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is WZ3105. The drug SMILES structure is CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C. Drug target is SRC, ROCK2, NTRK2, FLT3, IRAK1, others. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Best drug option: ?",CETUXIMAB
ACH-000107,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FTI-277. The drug SMILES structure is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
Drug 2: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Best drug option: ?",ARA-G
ACH-000139,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is PYRIMETHAMINE. The drug SMILES structure is CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl. Drug target is Dihydrofolate reductase (DHFR). Drug target pathway is Other.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Best drug option: ?",AGI-6780
ACH-000142,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
Drug 2: The drug is MIRA-1. The drug SMILES structure is CCC(=O)OCN1C(=O)C=CC1=O. Drug target is TP53. Drug target pathway is p53 pathway.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Best drug option: ?",FORETINIB
ACH-000147,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is UMI-77. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br. Drug target is MCL1. Drug target pathway is Apoptosis regulation.
Drug 2: The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Best drug option: ?",LESTAURTINIB
ACH-000148,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 3: The drug is BDP-00009066. The drug SMILES structure is CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC. Drug target is MRCKB_HUMAN. Drug target pathway is Cytoskeleton.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Best drug option: ?",FORETINIB
ACH-000169,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IWP-2. The drug SMILES structure is CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC4=C(C(=O)N3C5=CC=CC=C5)SCC4. Drug target is PORCN. Drug target pathway is WNT signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Best drug option: ?",KIN001-135
ACH-000212,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is VOXTALISIB. The drug SMILES structure is CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N. Drug target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Best drug option: ?",KIN001-135
ACH-000222,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is IRINOTECAN. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7. Drug target is TOP1. Drug target pathway is DNA replication.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Best drug option: ?",YK-4-279
ACH-000223,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
Drug 2: The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Best drug option: ?",AGI-5198
ACH-000263,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK429286A. The drug SMILES structure is CC1=C(C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(C=C4C(=C3)C=NN4)F. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Best drug option: ?",AZD8931
ACH-000267,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
Drug 3: The drug is XAV-939. The drug SMILES structure is C1CSCC2=C1N=C(NC2=O)C3=CC=C(C=C3)C(F)(F)F. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Best drug option: ?",AZD8931
ACH-000273,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is UPROSERTIB. The drug SMILES structure is CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000308,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 3: The drug is KIN001-270. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=NC(=C2)C3=CC(=CC=C3)N4C(=O)C5=CC=CC=C5C4=O)NS(=O)(=O)C. Drug target is CDK9. Drug target pathway is Other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Best drug option: ?",AZD8931
ACH-000320,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 3: The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Best drug option: ?",AVAGACESTAT
ACH-000338,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AXITINIB. The drug SMILES structure is CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4. Drug target is PDGFR, KIT, VEGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Best drug option: ?",BRYOSTATIN-1
ACH-000346,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is RIBOCICLIB. The drug SMILES structure is CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Best drug option: ?",BRYOSTATIN-1
ACH-000349,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 3: The drug is SU-11274. The drug SMILES structure is CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Best drug option: ?",GSK650394
ACH-000353,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 3: The drug is FTI-277. The drug SMILES structure is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Best drug option: ?",GSK650394
ACH-000369,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 2: The drug is AZD8055. The drug SMILES structure is C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Best drug option: ?",AGI-5198
ACH-000371,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK2126458. The drug SMILES structure is COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Best drug option: ?",AZD5363
ACH-000383,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
Drug 2: The drug is APR-246. The drug SMILES structure is COCC1(C(=O)C2CCN1CC2)CO. Drug target is TP53 activation. Drug target pathway is p53 pathway.
Drug 3: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Best drug option: ?",AGI-6780
ACH-000396,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is TRICHOSTATIN-A. The drug SMILES structure is CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000421,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
Drug 3: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Best drug option: ?",KIN001-135
ACH-000432,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 2: The drug is KIN001-260. The drug SMILES structure is C1CC1COC2=CC=CC(=O)C2=C3C=C(C(=C(N3)N)C#N)C4CCNCC4. Drug target is CDC7. Drug target pathway is DNA replication.
Drug 3: The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Best drug option: ?",AGI-6780
ACH-000438,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CCT007093. The drug SMILES structure is C1CC(=CC2=CC=CS2)C(=O)C1=CC3=CC=CS3. Drug target is PPM1D. Drug target pathway is Cell cycle.
Drug 2: The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
Drug 3: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Best drug option: ?",SARACATINIB
ACH-000482,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is MITOMYCIN-C. The drug SMILES structure is CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N. Drug target is DNA crosslinker. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Best drug option: ?",FORETINIB
ACH-000508,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
Drug 2: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 3: The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Best drug option: ?",AVAGACESTAT
ACH-000510,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
Drug 2: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 3: The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Best drug option: ?",ARA-G
ACH-000521,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 3: The drug is LCL-161. The drug SMILES structure is CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Best drug option: ?",YM-201636
ACH-000545,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
Drug 2: The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is AZD8055. The drug SMILES structure is C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Best drug option: ?",YM-201636
ACH-000561,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is BUPARLISIB. The drug SMILES structure is C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4. Drug target is PI3Kalpha, PI3Kdelta, PI3Kbeta, PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Best drug option: ?",AGI-6780
ACH-000586,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
Drug 2: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 3: The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Best drug option: ?",AZD5363
ACH-000638,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is VOXTALISIB. The drug SMILES structure is CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N. Drug target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Best drug option: ?",ARA-G
ACH-000657,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is UPROSERTIB. The drug SMILES structure is CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
Drug 3: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Best drug option: ?",VX-11E
ACH-000663,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 2: The drug is S-TRITYL-L-CYSTEINE. The drug SMILES structure is C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SC[C@@H](C(=O)O)N. Drug target is KIF11. Drug target pathway is Mitosis.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Best drug option: ?",YK-4-279
ACH-000725,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Best drug option: ?",KIN001-135
ACH-000740,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 2: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 3: The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Best drug option: ?",GSK650394
ACH-000743,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CANERTINIB. The drug SMILES structure is C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
Drug 3: The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Best drug option: ?",FORETINIB
ACH-000745,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 2: The drug is PIPERLONGUMINE. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O. Drug target is Induces reactive oxygen species. Drug target pathway is Other.
Drug 3: The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Best drug option: ?",AGI-5198
ACH-000750,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is VINBLASTINE. The drug SMILES structure is CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
Drug 3: The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Best drug option: ?",BRYOSTATIN-1
ACH-000751,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is HG-5-88-01. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC(=C2Cl)N)NC3=C(C=C(C=C3)N4CCC(CC4)C(=O)N)OC. Drug target is TAK1, M4K2. Drug target pathway is Other, kinases.
Drug 2: The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
Drug 3: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Best drug option: ?",YK-4-279
ACH-000802,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Best drug option: ?",AGI-6780
ACH-000815,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is PICOLINICI-ACID. The drug SMILES structure is C1=CC=NC(=C1)C(=O)O. Drug target is Inflammatory related. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Best drug option: ?",AGI-5198
ACH-000818,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 2: The drug is P22077. The drug SMILES structure is CC(=O)C1=CC(=C(S1)SC2=C(C=C(C=C2)F)F)[N+](=O)[O-]. Drug target is USP7, USP47. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Best drug option: ?",KIN001-135
ACH-000819,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AT-7519. The drug SMILES structure is C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl. Drug target is CDK1, CDK2, CDK4, CDK6, CDK9. Drug target pathway is Cell cycle.
Drug 2: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
Drug 3: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Best drug option: ?",AGI-5198
ACH-000828,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 2: The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Best drug option: ?",BRYOSTATIN-1
ACH-000864,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is PRT062607. The drug SMILES structure is C1CC[C@H]([C@H](C1)N)NC2=NC=C(C(=N2)NC3=CC=CC(=C3)N4N=CC=N4)C(=O)N. Drug target is SYK. Drug target pathway is Other, kinases.
Drug 2: The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
Drug 3: The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Best drug option: ?",KIN001-135
ACH-000865,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 2: The drug is WEHI-539. The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1.Cl. Drug target is BCL-XL. Drug target pathway is Apoptosis regulation.
Drug 3: The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Best drug option: ?",AGI-5198
ACH-000873,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
Drug 2: The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
Drug 3: The drug is GSK2126458. The drug SMILES structure is COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Best drug option: ?",GSK2606414
ACH-000876,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 2: The drug is CARMUSTINE. The drug SMILES structure is C(CCl)NC(=O)N(CCCl)N=O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Best drug option: ?",BRYOSTATIN-1
ACH-000936,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 2: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is FTI-277. The drug SMILES structure is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Best drug option: ?",GSK650394
ACH-000950,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
Drug 3: The drug is ALPELISIB. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Best drug option: ?",VX-11E
ACH-000953,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
Drug 2: The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Best drug option: ?",LESTAURTINIB
ACH-000989,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
Drug 2: The drug is JNK-9L. The drug SMILES structure is C1COCCN1C2=CC(=CC(=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5C=NC(=N5)N6CCOCC6)F. Drug target is JNK2, JNK3. Drug target pathway is JNK and p38 signaling.
Drug 3: The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Best drug option: ?",AGI-6780
ACH-000999,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
Drug 2: The drug is C-75. The drug SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. Drug target is FAS. Drug target pathway is Apoptosis regulation.
Drug 3: The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Best drug option: ?",AZD8931
ACH-001106,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
Drug 2: The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
Drug 3: The drug is SABUTOCLAX. The drug SMILES structure is CC1=CC2=C(C(=C(C=C2C(=C1C3=C(C4=CC(=C(C(=C4C=C3C)C(=O)NC[C@H](C)C5=CC=CC=C5)O)O)O)O)O)O)C(=O)NC[C@H](C)C6=CC=CC=C6. Drug target is BCL2,  BCL-XL,  BFL1, MCL1. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Best drug option: ?",GSK650394
ACH-001151,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
Drug 2: The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Best drug option: ?",BRYOSTATIN-1
ACH-001190,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CAY10603. The drug SMILES structure is CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC1, HDAC6. Drug target pathway is Chromatin histone acetylation.
Drug 2: The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
Drug 3: The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Best drug option: ?",IMATINIB
ACH-001374,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 2: The drug is P22077. The drug SMILES structure is CC(=O)C1=CC(=C(S1)SC2=C(C=C(C=C2)F)F)[N+](=O)[O-]. Drug target is USP7, USP47. Drug target pathway is Protein stability and degradation.
Drug 3: The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Best drug option: ?",AZD8931
ACH-001496,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
Drug 2: The drug is PEVONEDISTAT. The drug SMILES structure is C1CC2=CC=CC=C2[C@H]1NC3=NC=NC4=C3C=CN4[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N. Drug target is NAE. Drug target pathway is Other.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Best drug option: ?",ARA-G
ACH-001525,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is UMI-77. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br. Drug target is MCL1. Drug target pathway is Apoptosis regulation.
Drug 2: The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
Drug 3: The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Best drug option: ?",VX-11E
ACH-001530,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is WNT-C59. The drug SMILES structure is CC1=NC=CC(=C1)C2=CC=C(C=C2)CC(=O)NC3=CC=C(C=C3)C4=CN=CC=C4. Drug target is PORCN. Drug target pathway is WNT signaling.
Drug 2: The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
Drug 3: The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Best drug option: ?",AVAGACESTAT
ACH-001654,"Think step by step and decide the best drug option for the cell line with given mutations: [Drug Name], [Reasoning].
Drug 1: The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
Drug 2: The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
Drug 3: The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Best drug option: ?",ARA-G
